Month: September 2019
Meet with Christopher Kata, Director of Sales & Marketing on September 26th at the MaRS Startup Open House in Toronto, Ontario, Canada. Christopher Kata, Director of Sales & Marketing905 [email protected] MaRS Startup Open House When: September 26th 4:00 pm -7:00 pmWhere: MaRS Building – Toronto, Ontario CanadaRegister: https://www.eventbrite.ca/e/mars-startup-open-house-tickets-69880164453 Christopher Kata is attending the MaRS Startup…
Read More
Sponsors and technology vendors need to work together to develop innovative new ways to streamline the clinical trial process Ochsner Health System and Pfizer have embarked on a multi-year alliance to enhance the clinical trial experience and ease participation in clinical research for both patients and healthcare professionals. “The alliance aims to create faster, improved…
Read More
More and more Sponsors are looking to take advantage of Virtual and Hybrid Clinical Trials. Outsourcing Pharma published a very interesting article on this topic. “In their purest form, virtual clinical trials eliminate the need for study sites. A range of technologies and processes cover the tasks normally performed at sites. Participants can enroll and…
Read More
Medical Design & Outsourcing has published an article regarding FDA’s recent announcement require Medical Device manufacturers to provide more Real World Evidence for certain premarket approvals or risk losing those approvals. To read the entire article, click the button below. Continue Reading The Entire Article
Read More
Meet with Christopher Kata, Director of Sales & Marketing on September 29th to October 2nd, 2019 in Baltimore, MA! Christopher Kata, Director of Sales & Marketing905 [email protected] SCDM 2019When: September 28th to October 2nd 2019Where: Baltimore, MA Christopher Kata is in Baltimore for SCDM 2019 both days and currently has several openings in his schedule.…
Read More
This year at DIA one of the overriding themes was with the value and benefit of Machine Learning and Artificial Intelligence. One of these sessions was of particular interest and a summary has since been published by DIA. “Assembling experts from the application and research side of drug discovery, the session AI in Drug Discovery…
Read More